{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:10Z","timestamp":1776920530212,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.cancergencyto.2003.08.018","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T16:00:19Z","timestamp":1079712019000},"page":"81-85","source":"Crossref","is-referenced-by-count":23,"title":["A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome"],"prefix":"10.1016","volume":"150","author":[{"given":"Antonella","family":"Zagaria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Anelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Albano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clelia","family":"Tiziana Storlazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arcangelo","family":"Liso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Grazia Roberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Buquicchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Liso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB3","unstructured":"Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer. Available at: http:\/\/www.cgap. nci.nih.gov\/Chromosomes\/Mitelman. Accessed July 2003."},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-4608(85)90059-7","article-title":"Translocation of c-abl1 to \u201cmasked\u201d Ph in chronic myeloid leukemia","volume":"18","author":"Hagemeijer","year":"1985","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90145-K","article-title":"Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement?","volume":"57","author":"Fitzgerald","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/j.1460-2075.1985.tb03683.x","article-title":"C-abl and bcr are rearranged in a Ph1-negative CML patient","volume":"4","author":"Bartram","year":"1985","journal-title":"EMBO J"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB7","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood.V73.4.1038.1038","article-title":"Cytogenetic and molecular analysis in Philadelphia negative CML","volume":"3","author":"Van der Plas","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/gcc.2870030405","article-title":"A complex chromosome rearrangement forms the BCR-ABL fusion gene in leukemic cells with a normal karyotype","volume":"3","author":"Morris","year":"1991","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB9","first-page":"981","article-title":"Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9)(p23;q34) translocation","volume":"9","author":"Jadayel","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB10","first-page":"149","article-title":"Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias","volume":"40","author":"Aurich","year":"1998","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB11","first-page":"35","article-title":"Complex chromosome rearrangements may locate the bcr\/abl fusion gene sites other than 22q11","volume":"85","author":"Sessarego","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB12","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jnci\/90.11.850","article-title":"A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alpha","volume":"90","author":"Hasford","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.2294592","article-title":"High resolution mapping of human chromosomes 11 by in situ hybridization with cosmid clones","volume":"247","author":"Lichter","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia","volume":"13","author":"van Dongen","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB16","series-title":"An international system for human cytogenetic nomenclature","year":"1995"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/gcc.10116","article-title":"Breakpoint characterization of der(9) deletions in CML patients","volume":"35","author":"Storlazzi","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB18","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/0006-2952(92)90140-E","article-title":"Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues","volume":"43","author":"Diederich","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB19","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1074\/jbc.M008893200","article-title":"RINT-1, a novel Rad50-interacting protein, participates in radiation-induced G(2)\/M checkpoint control","volume":"276","author":"Xiao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/dnares\/6.5.337","article-title":"Prediction of the coding sequences of unidentified human genes","volume":"6","author":"Nagase","year":"1999","journal-title":"DNA Res"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000015298","article-title":"Cloning and characterization of a novel gene (C8orf2), a human representative of a novel gene family with homology to C. elegans C42.C1.9","volume":"85","author":"Ikegawa","year":"1999","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0165-4608(90)90030-E","article-title":"Cytogenetic peculiarities in chronic myelogenous leukemia","volume":"47","author":"Hild","year":"1990","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-4608(91)90129-I","article-title":"Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India","volume":"51","author":"Kadam","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0165-4608(00)00394-0","article-title":"Possible prediction of myeloid and lymphoid crises in chronic myelocytic leukemia at onset by determining the methylation status of the major breakpoint cluster region","volume":"126","author":"Ge","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/978-3-642-46836-0_6","article-title":"Delineation of genomic regions in chromosome band 7q22 commonly deleted in myeloid leukemias","volume":"44","author":"Fischer","year":"1998","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<384::AID-GCC11>3.0.CO;2-D","article-title":"Delineation of multiple deleted regions in 7q in myeloid disorders","volume":"25","author":"Tosi","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000046639","article-title":"The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1","volume":"107","author":"Macdonald","year":"2002","journal-title":"Acta Haematol"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB28","first-page":"887","article-title":"FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11\u201312","volume":"87","author":"Pebusque","year":"2000","journal-title":"Bull Cancer"},{"key":"10.1016\/j.cancergencyto.2003.08.018_BIB29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF03044856","article-title":"The 8p11 myeloproliferative syndrome","volume":"94","author":"Reither","year":"1999","journal-title":"Med Klin"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803003741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460803003741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T17:41:42Z","timestamp":1585676502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460803003741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0165460803003741"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2003.08.018","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}